Overview
Study information
Network: | CAVD |
Grant Affiliation: | Third party request |
Strategy: | Combo: DNA & protein vaccines |
Study Type: | Pre-Clinical Non-NHP |
Species: | Rabbit |
Stage: | Assays Completed |
Study Start Date: | 2012-04-04 |
Study Made Public: | 2012-08-14 |
Title
Rabbit Immunogenicity Study with a Clade A gp120 Env protein expressing the PG9 epitope in A3R5 assay (C0692-11)
Description
CAVD 361 (CAVIMC-041, C0692-11) is a preclinical rabbit study to compare the immunogenicity and induction of neutralizing antibodies to gp120 Env proteins discordant for binding to the PG9 broadly neutralizing antibody.
Sign in to see full information about this study and to download study data.
Products
Iscomatrix IAVI A1 gp120 DNA IAVI A1 gp120 Protein WT 16936 gp120 DNA WT 16936 gp120 Protein 16936-V55 chimera gp120 DNA 16936-V55 chimera gp120 Protein 16055-V36 chimera gp120 DNA 16055-V36 chimera gp120 Protein 16055 gp120 DNA 16055 gp120 Protein Control DNAIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.